Traders Purchase Large Volume of ALT5 Sigma Call Options (NASDAQ:ALTS)

ALT5 Sigma Corporation (NASDAQ:ALTS) was the recipient of unusually large options trading activity on Thursday. Investors acquired 8,298 call options on the stock. Thisisanincreaseof597% compared to the average volume of 1,190 call options.

ALT5 Sigma Stock Down 17.6%

Shares of ALTS opened at $5.94 on Friday. ALT5 Sigma has a fifty-two week low of $1.55 and a fifty-two week high of $10.95. The firm’s 50 day moving average price is $7.84 and its 200 day moving average price is $6.58. The company has a quick ratio of 0.83, a current ratio of 0.88 and a debt-to-equity ratio of 1.45.

Institutional Investors Weigh In On ALT5 Sigma

A number of large investors have recently modified their holdings of ALTS. Jane Street Group LLC purchased a new stake in shares of ALT5 Sigma in the 2nd quarter valued at approximately $380,000. Geode Capital Management LLC increased its position in shares of ALT5 Sigma by 27.6% in the 2nd quarter. Geode Capital Management LLC now owns 194,813 shares of the company’s stock valued at $1,412,000 after purchasing an additional 42,157 shares during the last quarter. Evernest Financial Advisors LLC purchased a new stake in shares of ALT5 Sigma in the 2nd quarter valued at approximately $87,000. Finally, Bridgeway Capital Management LLC increased its position in shares of ALT5 Sigma by 9.4% in the 2nd quarter. Bridgeway Capital Management LLC now owns 19,339 shares of the company’s stock valued at $140,000 after purchasing an additional 1,661 shares during the last quarter. 6.27% of the stock is owned by hedge funds and other institutional investors.

About ALT5 Sigma

ALT5 Sigma Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments.